Page 8 | Certara

Blog

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

Learn how regulatory expectations in clinical pharmacology are evolving and how to build a strategy…

CertaraMarch 24, 2026

Fact Sheet

How to Improve CRO Data Management

Read this fact sheet to learn how Pinnacle 21 Enterprise improves CRO data management and…

CertaraMarch 23, 2026

On-Demand Webinar

Leveraging the full potential of PBPK models to accelerate drug development

Explore how Novartis applies PBPK modeling in drug development using Simcyp to support regulatory decisions,…

CertaraMarch 20, 2026

Guide

From Numbers to Narrative: Mastering the Art of PK Presentation

Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…

CertaraMarch 20, 2026

Webinar

Pharmacometrics Under Pressure

CertaraMarch 20, 2026

Blog

What are Common Bioequivalence Study Mistakes?

Learn about the most common bioequivalence study mistakes drug developers make and the differences between…

CertaraMarch 20, 2026

Guide

Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer

Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…

CertaraMarch 19, 2026

Press Coverage Video

Rethinking Trial Design With Bayesian Approaches

Learn how Bayesian approaches are transforming clinical trial design by enabling adaptive studies, data borrowing,…

CertaraMarch 19, 2026

Blog

The future of payer engagement in pharma: rethinking how value is communicated

A detailed analysis of strategies for payer engagement in pharma and how digital payer engagement…

CertaraMarch 19, 2026

Blog Knowledge Base

What is GLP (Good Laboratory Practice)?

Read this blog to understand GLP (Good Laboratory Practice) and associated QA audits, and proper…

CertaraMarch 18, 2026

Regulatory horizons 2026: clinical pharmacology strategy and regulatory expectations

How to Improve CRO Data Management

Leveraging the full potential of PBPK models to accelerate drug development

From Numbers to Narrative: Mastering the Art of PK Presentation

Pharmacometrics Under Pressure

What are Common Bioequivalence Study Mistakes?

Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer

Rethinking Trial Design With Bayesian Approaches

The future of payer engagement in pharma: rethinking how value is communicated

What is GLP (Good Laboratory Practice)?

Newsletter sign up

Quick links

Solutions

Contact